性与性别少数人群的前列腺癌筛查模式
该横断面研究利用2014-2016及2018年行为风险因素监测系统数据,评估 LGBT 成人前列腺特异性抗原(PSA)筛查及决策模式。与顺性别异性恋相比,顺性别男同性恋/双性恋者更可能接受 PSA 筛查,顺性别男同性恋者更可能做出知情决策和参与共享决策。
要点
- 顺性别男同性恋和双性恋者 PSA 筛查率高于顺性别异性恋者。
- 顺性别男同性恋者更可能参与知情决策和共享决策。
- 跨性别个体接受前列腺癌筛查和做出知情决策的可能性较低。
核心结论
- 性与性别少数人群中,顺性别男同性恋和双性恋者前列腺癌筛查及知情/共享决策参与度较高,但跨性别个体筛查和知情决策参与度较低。
主要发现
- 与顺性别异性恋者相比,顺性别男同性恋者接受 PSA 筛查的比值比(OR)为1.07(p < 0.001),顺性别双性恋者为1.06(p < 0.001)。
- 顺性别男同性恋者做出知情决策的 OR 为1.10(p < 0.001),参与共享决策的 OR 为2.55(p < 0.001)。
- 跨性别个体接受前列腺癌筛查和做出知情决策的可能性较低。
临床怎么用
- 临床医生应关注性与性别少数人群的前列腺癌筛查决策需求,尤其需针对跨性别个体加强筛查和知情决策支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
One in six gay and bisexual men will be diagnosed with prostate cancer in their lifetime. Lesbian, gay, bisexual, and transgender (LGBT) populations are under-represented in cancer research, and guidelines on prostate-specific antigen (PSA) screening are limited. We performed a cross-sectional study to assess patterns of PSA screening and decision-making in this cohort. The Behavioral Risk Factor Surveillance System database was queried for LGBT adults for 2014-2016 and 2018, when PSA questions were asked in the annual survey. Multivariable logistic regression was performed to evaluate the association of LGBT status with PSA screening and informed and shared decision-making. A total of 164 370 participants were eligible for PSA screening, representing a weighted estimate of 1.2 million LGBT individuals. Compared to cisgender (CG) straight individuals, CG gay/bisexual cohorts were more likely to participate in PSA screening (CG gay: odds ratio [OR] 1.07; p < 0.001; CG bisexual: OR 1.06; p < 0.001). CG gay participants were more likely to make informed decisions (OR 1.10; p < 0.001) and engage in shared decision-making (OR 2.55; p < 0.001). Select gay populations were more likely to undergo PSA screening recommended by their clinicians and participate in informed and shared decision-making. PATIENT SUMMARY: This large study of sexual and gender minorities in the USA suggests that gay and bisexual individuals were more likely to undergo prostate cancer screening and that select gay individuals were more likely to make informed and shared decisions. However, transgender individuals were less likely to have prostate cancer screening and make informed decisions.
引用
- Ma SJ, Oladeru OT, Wang K, et al. Prostate Cancer Screening Patterns Among Sexual and Gender Minority Individuals. Eur Urol. 2020. PMID: 33250303. doi:10.1016/j.eururo.2020.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。